Ambient Air Pollution and Atherosclerosis: A Potential Mediating Role of Sphingolipids
- 1 July 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (7) , 906-918
Abstract
Background: The pathophysiological mechanisms of air pollution-induced atherosclerosis are incompletely understood. Sphingolipids serve as biological intermediates during atherosclerosis development by facilitating production of proatherogenic apoB (apolipoprotein B)-containing lipoproteins. We explored whether sphingolipids mediate the proatherogenic effects of air pollution. Methods: This was a prospective panel study of 110 participants (mean age 56.5 years) followed from 2013 to 2015 in Beijing, China. Targeted lipidomic analyses were used to quantify 24 sphingolipids in 579 plasma samples. The mass concentrations of ambient particulate matter ≤2.5 μm in diameter (PM 2.5 ) were continuously monitored by a fixed station. We evaluated the associations between sphingolipid levels and average PM 2.5 concentrations 1–30 days before clinic visits using linear mixed-effects models and explored whether sphingolipids mediate PM 2.5 -associated changes in the levels of proatherogenic apoB-containing lipoproteins (LDL-C [low-density lipoprotein cholesterol] and non-HDL-C [nonhigh-density lipoprotein cholesterol]) using mediation analyses. Results: We observed significant increases in the levels of non-HDL-C and fourteen sphingolipids associated with PM 2.5 exposure, from short- (14 days) to medium-term (30 days) exposure time windows. The associations exhibited near-monotonic increases and peaked in 30-day time window. Increased levels of the sphingolipids, namely, sphinganine, ceramide C24:0, sphingomyelins C16:0/C18:0/C18:1/C20:0/C22:0/C24:0, and hexosylceramides C16:0/C18:0/C20:0/C22:0/C24:0/C24:1 significantly mediated 32%, 58%, 35% to 93%, and 23% to 86%, respectively, of the positive association between 14-day PM 2.5 average and the non-HDL-C level, but not the LDL-C level. Similar mediation effects (19%–91%) of the sphingolipids were also observed in 30-day time window. Conclusions: Our results suggest that sphingolipids may mediate the proatherogenic effects of short- and medium-term PM 2.5 exposure.Keywords
This publication has 49 references indexed in Scilit:
- Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS)Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011
- Distributed lag non‐linear modelsStatistics in Medicine, 2010
- Particulate Matter Air Pollution and Cardiovascular DiseaseCirculation, 2010
- Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Subendothelial Lipoprotein Retention as the Initiating Process in AtherosclerosisCirculation, 2007
- Utility of Non–High-Density Lipoprotein Cholesterol Versus Other Lipoprotein Measures in Detecting Subclinical Atherosclerosis in Young Adults (The Bogalusa Heart Study)The American Journal of Cardiology, 2007
- Coarse Particulate Matter (PM 2.5–10 ) Affects Heart Rate Variability, Blood Lipids, and Circulating Eosinophils in Adults with AsthmaEnvironmental Health Perspectives, 2007
- Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout miceAtherosclerosis, 2006
- Inhibition of Sphingomyelin Synthesis Reduces Atherogenesis in Apolipoprotein E–Knockout MiceCirculation, 2004